143 related articles for article (PubMed ID: 24411757)
1. Influence of eating behaviors on short-term weight loss by orlistat and anorectic agent.
Kim KK; Suh HS; Hwang IC; Ko KD
Eat Behav; 2014 Jan; 15(1):87-90. PubMed ID: 24411757
[TBL] [Abstract][Full Text] [Related]
2. Who will lose weight on sibutramine and orlistat? Psychological correlates for treatment success.
Elfhag K; Finer N; Rössner S
Diabetes Obes Metab; 2008 Jun; 10(6):498-505. PubMed ID: 17593239
[TBL] [Abstract][Full Text] [Related]
3. Effect of orlistat on eating behavior among participants in a 3-year weight maintenance trial.
Svendsen M; Rissanen A; Richelsen B; Rössner S; Hansson F; Tonstad S
Obesity (Silver Spring); 2008 Feb; 16(2):327-33. PubMed ID: 18239640
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacological therapy of obesity].
Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
[TBL] [Abstract][Full Text] [Related]
5. Long-term pharmacotherapy for obesity and overweight.
Padwal R; Li SK; Lau DC
Cochrane Database Syst Rev; 2003; (4):CD004094. PubMed ID: 14584004
[TBL] [Abstract][Full Text] [Related]
6. Orlistat and sibutramine beyond weight loss.
Mannucci E; Dicembrini I; Rotella F; Rotella CM
Nutr Metab Cardiovasc Dis; 2008 Jun; 18(5):342-8. PubMed ID: 17928208
[TBL] [Abstract][Full Text] [Related]
7. Long-term changes in blood pressure following orlistat and sibutramine treatment: a meta-analysis.
Johansson K; Sundström J; Neovius K; Rössner S; Neovius M
Obes Rev; 2010 Nov; 11(11):777-91. PubMed ID: 20025693
[TBL] [Abstract][Full Text] [Related]
8. Clinical pharmacotherapy for obesity: current drugs and those in advanced development.
Halford JC
Curr Drug Targets; 2004 Oct; 5(7):637-46. PubMed ID: 15473253
[TBL] [Abstract][Full Text] [Related]
9. The effectiveness of pharmaceutical interventions for obesity: weight loss with orlistat and sibutramine in a United Kingdom population-based cohort.
Douglas IJ; Bhaskaran K; Batterham RL; Smeeth L
Br J Clin Pharmacol; 2015 Jun; 79(6):1020-7. PubMed ID: 25641659
[TBL] [Abstract][Full Text] [Related]
10. Effects of sibutramine plus orlistat in obese women following 1 year of treatment by sibutramine alone: a placebo-controlled trial.
Wadden TA; Berkowitz RI; Womble LG; Sarwer DB; Arnold ME; Steinberg CM
Obes Res; 2000 Sep; 8(6):431-7. PubMed ID: 11011909
[TBL] [Abstract][Full Text] [Related]
11. Systematic review of the clinical efficacy of sibutramine and orlistat in weigth loss, quality of life and its adverse effects in obese adolescents.
García Díaz E; Martín Folgueras T
Nutr Hosp; 2011; 26(3):451-7. PubMed ID: 21892560
[TBL] [Abstract][Full Text] [Related]
12. The effects of anti-obesity intervention with orlistat and sibutramine on microvascular endothelial function.
Al-Tahami BA; Ismail AA; Bee YT; Awang SA; Salha Wan Abdul Rani WR; Sanip Z; Rasool AH
Clin Hemorheol Microcirc; 2015; 59(4):323-34. PubMed ID: 24002121
[TBL] [Abstract][Full Text] [Related]
13. Add-on combination and maintenance treatment: case series of five obese patients with different eating behavior.
Anghelescu I; Klawe C; Szegedi A
J Clin Psychopharmacol; 2002 Oct; 22(5):521-4. PubMed ID: 12352278
[TBL] [Abstract][Full Text] [Related]
14. NPY5R antagonism does not augment the weight loss efficacy of orlistat or sibutramine.
Erondu N; Addy C; Lu K; Mallick M; Musser B; Gantz I; Proietto J; Astrup A; Toubro S; Rissannen AM; Tonstad S; Haynes WG; Gottesdiener KM; Kaufman KD; Amatruda JM; Heymsfield SB
Obesity (Silver Spring); 2007 Aug; 15(8):2027-42. PubMed ID: 17712121
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of sibutramine, orlistat and combination therapy on short-term weight management in obese patients.
Kaya A; Aydin N; Topsever P; Filiz M; Oztürk A; Dağar A; Kilinç E; Ekmekcioglu C
Biomed Pharmacother; 2004 Dec; 58(10):582-7. PubMed ID: 15589067
[TBL] [Abstract][Full Text] [Related]
16. Effects of sibutramine and orlistat on mood in obese and overweight subjects: a randomised study.
Kiortsis DN; Tsouli S; Filippatos TD; Konitsiotis S; Elisaf MS
Nutr Metab Cardiovasc Dis; 2008 Mar; 18(3):207-10. PubMed ID: 17570651
[TBL] [Abstract][Full Text] [Related]
17. Comparison of metabolic effects of orlistat and sibutramine treatment in Type 2 diabetic obese patients.
Derosa G; Cicero AF; Murdolo G; Ciccarelli L; Fogari R
Diabetes Nutr Metab; 2004 Aug; 17(4):222-9. PubMed ID: 15575343
[TBL] [Abstract][Full Text] [Related]
18. The first decade of sibutramine and orlistat: a reappraisal of their expanding roles in the treatment of obesity and associated conditions.
Coutinho W
Arq Bras Endocrinol Metabol; 2009 Mar; 53(2):262-70. PubMed ID: 19466219
[TBL] [Abstract][Full Text] [Related]
19. Effects of sibutramine on binge eating, hunger, and fullness in a laboratory human feeding paradigm.
Mitchell JE; Gosnell BA; Roerig JL; de Zwaan M; Wonderlich SA; Crosby RD; Burgard MA; Wambach BN
Obes Res; 2003 May; 11(5):599-602. PubMed ID: 12740447
[TBL] [Abstract][Full Text] [Related]
20. Anti-obesity drugs.
Proietto J
Med J Aust; 1998 Apr; 168(8):409-12. PubMed ID: 9594954
[No Abstract] [Full Text] [Related]
[Next] [New Search]
